Flexbumin Approval History
- FDA approved: Yes (First approved October 17th, 2005)
- Brand name: Flexbumin
- Generic name: albumin human
- Company: Baxter Healthcare Corporation
- Treatment for: Plasma Volume Expansion
Flexbumin (albumin human) is the first human serum albumin preparation packaged in a flexible container (previously packaged in glass bottles). Flexbumin is indicated in hypovolemia, hypoalbuminemia due to inadequate reproduction, excessive catabolism, hemorrhage, major surgery or burns, and for use during cardiopulmonary bypass surgery.
Development History and FDA Approval Process for Flexbumin
|Oct 17, 2005||Flexbumin Baxter Healthcare Corporation - Treatment for Plasma Volume Expansion|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.